FDA, Covid and vaccines
Digest more
Top News
Overview
Impacts
The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.
Dr. Peter McCullough testified Thursday at a Senate hearing on "The Corruption of Science and Federal Health Agencies: How Health Officials Downplayed and Hid Myocarditis and Other Adverse Events Associated with the COVID-19 Vaccines.
The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr. Philip Dormitzer, may have “conspired to withhold public
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy
Overall, women who received a COVID vaccine had a 19% greater risk of increase in menstrual cycle length as compared to unvaccinated women or women in pre-vaccination time periods (summary relative risk [sRR], 1.19; 95% confidence interval [CI], 1.11 to 1.26).
4d
Asianet Newsable on MSNNovavax Wins FDA Approval For COVID-19 Vaccine: Retail Calls For Buyback And Bigger MovesThe pharma company secured FDA clearance to manufacture and distribute its COVID-19 vaccine Nuvaxovid for adults and at-risk groups, with no advisory committee hurdles.